Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (381-390 of 755) with videos related to

Pageof 76
Sort By:
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Journal of the American Dental Association (1939)|June 1, 1977
Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma)S C White, N W Frey, D D Blaschke, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.
Journal of Scleroderma and Related Disorders|May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortSangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
The American Journal of Medicine|February 1, 1994
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse eventsK G Saag, R Koehnke, J R Caldwell, et al.
RMD Open|January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysisPhilip J Mease, Soumya Reddy, Sarah Ross, et al.
Journal of Clinical Epidemiology|November 13, 2015
Modified intention-to-treat analysis did not bias trial resultsAnna Dossing, Simon Tarp, Daniel E Furst, et al.
Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Arthritis and Rheumatism|August 18, 2001
Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosisK L Johnson, J L Nelson, D E Furst, et al.
Pageof 76

Showing results (381-390 of 755) with videos related to

Sort By:
Pageof 76
The Journal of Rheumatology|September 12, 2008
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA databaseVeena K Ranganath, Harold E Paulus, Alina Onofrei, et al.
Journal of the American Dental Association (1939)|June 1, 1977
Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma)S C White, N W Frey, D D Blaschke, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.
Journal of Scleroderma and Related Disorders|May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortSangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
The American Journal of Medicine|February 1, 1994
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse eventsK G Saag, R Koehnke, J R Caldwell, et al.
RMD Open|January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysisPhilip J Mease, Soumya Reddy, Sarah Ross, et al.
Journal of Clinical Epidemiology|November 13, 2015
Modified intention-to-treat analysis did not bias trial resultsAnna Dossing, Simon Tarp, Daniel E Furst, et al.
Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Arthritis and Rheumatism|August 18, 2001
Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosisK L Johnson, J L Nelson, D E Furst, et al.
Pageof 76